Latest
-
Clinical Trials in Canada: Worrying Signs that PMPRB Changes will Impact Research Investment
Nigel S B Rawson, PhD »
-
Patented Medicines Expenditure in Canada 1990-2018
Are government price controls justified by the cost of innovative pharmaceuticals? CHPI RESEARCH REPORT »
-
Canada’s Vaccine Development Capacity and the Federal Government’s Management of COVID-19
Paul Lucas, Retired President and CEO GlaxoSmithKline. »
-
E-Mental Health Services and Unmet Needs of Canadians
Opportunities to Improve Mental Health During and After COVID-19 Pandemic. Mark Embrett, PhD. »
-
Career Options and Professional Integration of Internationally Trained Physicians in Canada.
Could International Medical Graduates solve our shortage of healthcare professionals in Canada? Sanjida Newaz, MBBS, MSc. »
-
Universal public funding for dental care in Canada: problems, policies, and politics.
Should dental care be funded like medicare? Homam Albaghdadi, DDS. »
-
Ensuring early access to a COVID-19 vaccine in Canada.
Policy solutions include Regulatory Harmonization, Fair Market Prices, and Intellectual Property Rights. Brett Skinner, PhD. »
-
Vaccines policy in Canada: International and Domestic Comparisons.
This paper compares the policy environments for vaccines in Canada, Australia, United Kingdom, New Zealand, and the United States. Brett Skinner, PhD. »